Report Code: A10548 | Pages: NA | Mar 2023 | 1403 Views | ||
Author(s) : NA | Tables: NA | Charts: NA |
|
Pandemic disrupted the entire world and affected many industries.
Get detailed COVID-19 impact analysis on the Womens Healthcare Care Market
Request Now !Women’s healthcare is the need of the hour due to the growth in the diseases and complications caused to the women in the current scenario. The women healthcare includes complete emphasis and focus over the wellbeing of the women by ensuring appropriate diagnosis and treatment. Women experience various problems during and postmenstrual cycle, which is common amongst women. Furthermore, the diseases which are mostly prevalent among the women include various urological disorders, poly cystic ovarian syndrome and other post-menopausal complications. There are various medications which are available for controlling the birth and also for the regulation of hormones, which is a major challenge. During pregnancy and post-pregnancy the hormonal disturbances are experienced by the majority of women, the management of which are important and is in demand for the next few years.
Market scope and structure analysis:
Report Metric | Details |
Market size available for years | 2020–2027 |
Base year considered | 2019 |
Forecast period | 2021–2027 |
Forecast units | Value (USD) |
Segments covered | Drug, Application, Distribution Channel and Region |
Regions covered | North America (U.S. and Canada), Europe (Germany, UK, France, and the Rest of Europe), Asia-Pacific (China, Japan, India, and the Rest of Asia-Pacific), Latin America (Brazil, Mexico, and the Rest of LATAM) and The Middle East and Africa |
Companies covered | Major players analyzed include Bayer AG, Ferring Pharmaceuticals, Amgen, Agile Therapeutics Inc., Apothecus Pharmaceutical, Pfizer Inc., Mylan N.V., Lupin, Merck & Co. and Blairex Laboratories. |
COVID-19 scenario analysis:
Coronavirus disease 2019 (COVID-19) has created an economic crisis along with a health care crisis. COVID-19 pandemic has brought an enforced lockout which stopped major sectors from earning revenue and hence led to the recession in the current scenario. The Covid-19 pandemic has a severe impact on the healthcare system, causing in 50% to 70% drop in revenue from March. There is a shut-down of many small hospitals, clinics and nursing homes to stop the spread of the disease. The law also forced the doctors to reduce the number of surgical procedures in this duration. In addition, visa cancellations have led to a reduction in medical tourism and can negatively impact the healthcare services market growth.
The key factors that are anticipated to help the market grow include rise in concern of the government for controlling population inflation and increase in the incidences of chronic health conditions such as endometriosis and urinary incontinence. The surge in the R&D of the women’s healthcare products and increase in the demand for the medications, which are used to prevent the unintended pregnancies would help the market propel in the coming years. However, the rising product recalls may hinder the growth of industry for the commenced period.
The key market players are focusing over the development of the products and hence, gain attention to attain maximum revenue in the forecast period. For instance, in June 2019, U.S. Food and Drug Administration declared that it approved Vyleesi. This was claimed to assist in the treatment of generalized hypoactive sexual desire disorder (HSDD) in premenopausal women. The rise in the product approvals and the government concern for the development of such products would boost the market
Furthermore, in February 2020, Agile Therapeutics, Inc., which is amongst the women’s healthcare company, announced that the U.S. Food and Drug Administration (FDA) approved Twirla transdermal system. This is indicated as a method of contraception for usage in women of reproductive potential with a BMI < 30 kg/m2 for whom a combined hormonal contraceptive.
The market leaders are focusing to enhance their presence in the market by getting into definitive agreements with the other key leaders. For instance, in July 2019, Pfizer declared that it had acquired Matrix Pharma, which has various products in anti-HIV and women’s health categories. In addition, the combination of two companies in India is expected to be around $500 million, and it might help Pfizer to get to the number 10th position in the $5 billion Indian pharma market, was according to figures from AWACS, a pharma consulting firm.
Furthermore, in October 2017, Lupin acquired women’s health company in the U.S. for approximately $150 million. The complete acquisition of Symbiomix and the ‘Solosec’ franchise would help Lupin to expand its women’s health specialty business and hence, gain maximum shares in the market. Lupin is expected to pay $50 million upfront and the residual amount about $100 million over the coming years.
Key segments covered:
Segments | Sub-segments |
Drug |
|
Application |
|
Distribution channel |
|
Key benefits of the report:
Questions answered in the Women’s Healthcare Care Market research report:
Womens Healthcare Care Market: Global Opportunity Analysis and Industry Forecast, 2019–2026 Report Highlights
Aspects | Details |
---|---|
By Drug |
|
By Application |
|
By Distribution channel |
|
By Region |
|
Key Market Players | Bayer AG,, Ferring Pharmaceuticals,, Amgen,, Agile Therapeutics Inc.,, Apothecus Pharmaceutical,, Pfizer Inc.,, Mylan N.V.,, Lupin,, Merck & Co., Blairex Laboratories. |
Loading Table Of Content...
Start reading.
This Report and over 19,614+ more Reports, Available with Avenue Library. T&C*.
Enterprise
License/PDF
Library
Membership
*Taxes/Fees, if applicable will be added during checkout. All prices in USD
To ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time of readers
Get insights on topics that are crucial for your business. Stay abreast of your interest areas.
Get Industry Data AlertsTo ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time of readers